Agilent authorizes new share repurchase program Agilent's board of directors has authorized the repurchase of up to $500M of the companyís common stock during fiscal 2013. The new repurchase authorization replaces Agilentís existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.
Dako announces collaboration agreement with Amgen Dako, an Agilent Technologies (A) company, announced a new Master Collaboration Agreement with Amgen (AMGN). The expanded collaboration will allow both companies to benefit from knowledge-sharing within the field of drug-diagnostic research and development in general, and in relation to companion diagnostic products in particular. The financial details of the agreement were not disclosed.